EDITORIAL
Published on 08 Sep 2020
Editorial: Death Receptors, Non-apoptotic Signaling Pathways and Inflammation
doi 10.3389/fimmu.2020.02162
- 1,961 views
- 4 citations
- Frontiers in Immunology
- Inflammation
- Research Topics
- Death Receptors, Non-Apoptotic Signaling Pathways and Inflammation
Death Receptors, Non-Apoptotic Signaling Pathways and Inflammation
20k
Total downloads
90k
Total views and downloads
Articles
CORRECTION
Published on 22 Oct 2019
Corrigendum: The TNF Paradox in Cancer Progression and Immunotherapy
doi 10.3389/fimmu.2019.02515
- 1,876 views
- 8 citations
ORIGINAL RESEARCH
Published on 29 Aug 2019
TRAF2 Controls Death Receptor-Induced Caspase-8 Processing and Facilitates Proinflammatory Signaling
doi 10.3389/fimmu.2019.02024
- 4,863 views
- 17 citations
ORIGINAL RESEARCH
Published on 28 Aug 2019
TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells
doi 10.3389/fimmu.2019.02044
- 7,826 views
- 34 citations
OPINION
Published on 31 Jul 2019
The TNF Paradox in Cancer Progression and Immunotherapy
doi 10.3389/fimmu.2019.01818
- 39,870 views
- 240 citations
ORIGINAL RESEARCH
Published on 17 Jul 2019
Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease
doi 10.3389/fimmu.2019.01624
- 4,480 views
- 18 citations
REVIEW
Published on 03 Jul 2019
Multiple Interactions Between Cancer Cells and the Tumor Microenvironment Modulate TRAIL Signaling: Implications for TRAIL Receptor Targeted Therapy
doi 10.3389/fimmu.2019.01530
- 8,804 views
- 65 citations
METHODS
Published on 04 Jun 2019
Evaluation of Canonical Inflammasome Activation in Human Monocytes by Imaging Flow Cytometry
doi 10.3389/fimmu.2019.01284
- 7,343 views
- 29 citations
ORIGINAL RESEARCH
Published on 30 Apr 2019
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
doi 10.3389/fimmu.2019.00951
- 7,925 views
- 20 citations
Published in
Frontiers in Immunology
Inflammation
Cancer Immunity and Immunotherapy
Alloimmunity and Transplantation
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore